Abstract

Abdominal aortic aneurysm (AAA) is the 13th leading cause of death in the United States, responsible for over 15,000 deaths annually. With improved screening methods and the advent of endovascular surgery, mortality from AAA has significantly decreased over the past twenty years [1]. Today it is estimated that >70% of aneurysms are amenable to endovascular repair [2]. While endovascular aortic aneurysm repair (EVAR) is confined to the treatment of infra-renal AAA with a ≥10 mm neck, complex endovascular stent grafts have been developed to treat AAA with <4 mm infra-renal neck (juxta-renal), involving the renal or visceral vessel orifices (para-renal or para-visceral), or extending to the diaphragm (Type IV thoraco-abdominal aneurysm) or thoracic aorta. It is estimated that 16% of infrarenal aortic aneurysms are juxta-renal, and a smaller percentage involve the more proximal abdominal aorta [3]. Fenestrated and branched endografts have been developed to treat proximal AAAs not amenable to standard EVAR. However, the extent of what can be treated is limited in the United States by the specific instructions for use (IFU) of each device and what has gone through the rigorous process of FDA approval. Instructions for use outline the recommended anatomic constraints for each device to maximize positive outcomes by guiding patient and device selection. Physicians can treat outside of the IFU but bear significant liability. While certain centers in the US conducting investigational research have access to order endografts outside of their IFU, practitioners in other countries are able to customize devices without these constraints. Patients who could otherwise undergo endovascular repair may be subject to high-risk open surgery, off-label use of devices to perform chimney/snorkel procedures, off-label use of existing FDA approved fenestrated devices, or medical management (at increased risk for aneurysm related death) due to these current restrictions.

Highlights

  • Endovascular management of complex aortic aneurysms has been evolving over the past two decades

  • Branched grafts have a main body with four cuffs, which are bridged with stent grafts to the celiac, superior mesenteric, and renal arteries

  • This poses the question whether 10-14 mm neck aneurysms may be more appropriately repaired by F-endovascular aortic aneurysm repair (EVAR) to decrease the risk of a type IA endoleak

Read more

Summary

Introduction

Endovascular management of complex aortic aneurysms has been evolving over the past two decades. Currently available off the shelf outside of the United States, are used for complex TAAA where supra-celiac coverage is necessary. Branched grafts have a main body with four cuffs, which are bridged with stent grafts to the celiac, superior mesenteric, and renal arteries.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.